The First Trust NYSE Arca Biotechnology UCITS ETF has reported its funds date, TIDM, ISIN code, shares in issue, currency, net asset value, and NAV per share as of January 25, 2024. The TIDM for the fund is FBTU.LN and its ISIN code is IE00BL0L0H60. As of the reported date, there are 325,002.00 shares in issue, and the currency for the fund is USD. The net asset value of the fund is 6,001,192.22, with a NAV per share of 18.465.
Investors and stakeholders can use this information to track the performance and value of the First Trust NYSE Arca Biotechnology UCITS ETF. As an exchange-traded fund, it provides investors with a way to access a diversified portfolio of biotechnology stocks traded on the NYSE Arca Exchange.
The biotechnology sector is known for its potential for growth and innovation, making it an attractive investment opportunity for many. By investing in the First Trust NYSE Arca Biotechnology UCITS ETF, investors can gain exposure to this dynamic and rapidly evolving industry.
With the provided fund information, investors can make informed decisions about their investment strategy and portfolio allocation. The net asset value and NAV per share are key metrics that investors use to evaluate the performance and value of their investments. By staying informed about these metrics, investors can adjust their investment strategy as needed to achieve their financial goals.
In conclusion, the First Trust NYSE Arca Biotechnology UCITS ETF has reported its funds date, TIDM, ISIN code, shares in issue, currency, net asset value, and NAV per share as of January 25, 2024. This information is valuable for investors and stakeholders who are interested in tracking the performance and value of the fund. As the biotechnology sector continues to grow and evolve, the First Trust NYSE Arca Biotechnology UCITS ETF provides investors with a way to access this dynamic industry and potentially benefit from its growth and innovation.
Source link
